alkeran
aspen pharma trading limited - melfalanas - milteliai ir tirpiklis injekciniam tirpalui - 50 mg; 2 mg - melphalan
melphalan zentiva
zentiva k.s. - melfalanas - milteliai ir tirpiklis injekciniam ar infuziniam tirpalui - 50 mg - melphalan
melphalan
lex ano, uab - melfalanas - milteliai ir tirpiklis injekciniam tirpalui - 50 mg - melphalan
alkacel
nenurodyta - melfalanas - tabletės - 2 mg - melphalan
alkacel
armila, uab - melfalanas - milteliai ir tirpiklis injekciniam tirpalui - 50 mg - melphalan
phelinun
adienne s.r.l. s.u. - melphalan hydrochloride - multiple myeloma; hodgkin disease; lymphoma, non-hodgkin; precursor cell lymphoblastic leukemia-lymphoma; leukemia, myeloid, acute; neuroblastoma; ovarian neoplasms; hematopoietic stem cell transplantation - antinavikiniai vaistai - high-dose of phelinun used alone or in combination with other cytotoxic medicinal products and/or total body irradiation is indicated in the treatment of:multiple myeloma,malignant lymphoma (hodgkin, non-hodgkin lymphoma),acute lymphoblastic and myeloblastic leukemia,childhood neuroblastoma,ovarian cancer,mammary adenocarcinoma. phelinun in combination with other cytotoxic medicinal products is indicated as reduced intensity conditioning (ric) treatment prior to allogeneic haematopoietic stem cell transplantation (allo-hsct) in malignant haematological diseases in adults. phelinun in combination with other cytotoxic medicinal products is indicated as conditioning regimen prior to allogeneic haematopoietic stem cell transplantation in haematological diseases in the paediatric population as:myeloablative conditioning (mac) treatment in case of malignant haematological diseasesric treatment in case of non-malignant haematological diseases.
alkeran
niromed, uab - melfalanas - milteliai ir tirpiklis injekciniam tirpalui - 50 mg - melphalan